“分配隱藏”很容易被誤解而被廣大臨床試驗實施者和論文作者所忽略，尤其是常將“分配隱藏”與盲法混淆。分配隱藏實質是產(chǎn)生隨機序列者和決定分配序別者不能參與納入受試者，也不宜參與以后的試驗過程，尤其不能參與結果的測量。本文通過實例介紹了正確的分配隱藏和盲法實施過程。最后，還舉例介紹了論文寫作中方法學的描述。
引用本文： 吳泰相,劉關鍵. 隱蔽分組（分配隱藏）和盲法的概念、實施與報告. 中國循證醫(yī)學雜志, 2007, 07(3): 222-225. doi: 復制
| 1. | Jadad AR. Randomised controlled trials, A user’s guide. [2007-01-26]http://www.cgmh.org.tw/intr/intr5/c6700/OBGYN/F/Randomized%20tial/chapter1.html. |
| 2. | Chalmers TC, Celano P, Sacks HS, et al. Bias in treatment assignment in controlled clinical trials. N Engl J Med, 1983, 309: 1359–1361. |
| 3. | Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 1995, 273: 408–412. |
| 4. | Schulz KF. Subverting randomization in controlled trials. JAMA, 1995, 274: 1456–1458. |
| 5. | Pildal J, Chan AW, Hróbjartsson A, et al. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ, 2005, 330: 1049. |
| 6. | Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet, 1996, 347: 363–366. |
- 1. Jadad AR. Randomised controlled trials, A user’s guide. [2007-01-26]http://www.cgmh.org.tw/intr/intr5/c6700/OBGYN/F/Randomized%20tial/chapter1.html.
- 2. Chalmers TC, Celano P, Sacks HS, et al. Bias in treatment assignment in controlled clinical trials. N Engl J Med, 1983, 309: 1359–1361.
- 3. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA, 1995, 273: 408–412.
- 4. Schulz KF. Subverting randomization in controlled trials. JAMA, 1995, 274: 1456–1458.
- 5. Pildal J, Chan AW, Hróbjartsson A, et al. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ, 2005, 330: 1049.
- 6. Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet, 1996, 347: 363–366.